JAN 02, 2017 9:20 AM PST

Sugar Molecule Demonstrated to Halt Emphysema Progression

WRITTEN BY: Carmen Leitch

Chronic obstructive pulmonary disease (COPD) is an umbrella term for diseaes of the lungs and airways, and includes emphysema, a disease that affects over 30 million people in the United States alone, and is the fourth leading cause of death in the world. Researchers working in collaboration at RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and several other institutes have found that a specific type of sugar molecule reduced the inflammatory response and progression of emphysema. According to the leader of the team that performed the work, Naoyuki Taniguchi, this discovery may open up the possibility of creating of drugs based on these biological sugar molecules in order to treat diseases like COPD. The findings were published in the American Journal of Physiology, Lung Cellular and Molecular Physiology. In the following video, learn more about emphysema.

Keratan sulfate is in a class of sugar or saccharide molecules called glycans. It resides in the small airways of the lung. The researchers determined that levels of the sugar are reduced in mice exposed to cigarette smoke. The researchers speculated that the alteration could be linked to damage in the lung caused by smoking. Taniguchi explained, "We are not absolutely sure of the mechanism through which smoking leads to a reduction in keratan sulfate, but felt that clearly the reduction is important in thinking about glycan-based strategies for combating emphysema and COPD."

To investigate whether keratan sulfate could play a protective role in COPD, the scientists engineered a molecule from repeated disaccharide units of keratan sulfate, termeed L4. The L4 was applied to two mouse models of emphysema, one in which the enzyme elastase is the cause, while the other modeled emphysema caused by smoking.

In that smoking model, L4 treatment was able to prevent destruction of the small air sacs in lungs that function to exchange gases, the alveoli. Additionally, L4 treatment reduced the penetration of neutrophils, a kind of white blood cell that indicates inflammation.  There was also a reduction in inflammatory cytokine and tissue-degrading enzyme levels. While L4 was demonstrated to inhibit the enzymes, L4 did not appear to reduce the production of cytokines or reactive oxygen species directly. As such, the investigators concluded that the effect was occurring indirectly, through mechanisms likely involving neutrophils.

"We found that L4 was as effective as dexamethasone in reducing neutrophil infiltration. This is very exciting, because dexamethasone, the treatment currently used for COPD, is a steroid medication that can have serious side effects and can in some cases make the outcome worse,” Taniguchi expained. “It will be exciting if we can show that L4--a sugar molecule which we found had no adverse effects in the mice even at high doses--can be used as a treatment for this condition, which exerts a tremendous health burden."

Taniguchi noted that more work lies ahead. "We plan now to try to determine exactly how L4 blocks neutrophil migration, by finding a target receptor protein, and how L4 can suppress inflammation in vivo, as this could give us important insights into the mechanism of COPD progression and how it can be halted."

 

Sources: AAAS/Eurekalert! via RIKEN, COPD Foundation, American Journal of Physiology, Lung Cellular and Molecular Physiology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 04, 2020
Immunology
JAN 04, 2020
Why Do Skincare Products Sometimes Cause Rashes?
Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system responsible for triggering allergic inf...
JAN 28, 2020
Cell & Molecular Biology
JAN 28, 2020
A Rare Genetic Disorder is Effectively Treated With Modified Stem Cells
A clinical trial used stem cell gene therapy to treat a rare genetic disorder called X-CGD. Image credit: UCLA Broad Stem Cell Research Center/Nature Medicine...
FEB 17, 2020
Neuroscience
FEB 17, 2020
New Evidence: How Genomic Instability and Replication Stress Relate to Autism Spectrum Disorder
Dr. Eric Courchesne of the University of California San Diego explains further consequences of DNA over-replication and macrocephaly. Researchers at the Un...
MAR 08, 2020
Cell & Molecular Biology
MAR 08, 2020
How a Decoy Strategy Helps Cells Evade the Effects of Pathogens
Scientists have identified a strategy used by cells to shield them from the toxins that can be released by dangerous bacterial pathogens....
MAR 16, 2020
Genetics & Genomics
MAR 16, 2020
How the Genetic Material in Sperm is Unpacked During Fertilization
The genetic material from a sperm and an egg merges to form a new human genome, and now we know more details about the process....
MAR 04, 2020
Neuroscience
MAR 04, 2020
Memories Are Stored As Specific Neural Firing Patterns
Scientists working on the EPFL Blue Brain Project explain the algebraic patterns of neuron activity.  Scientists at the National Institute of Health&r...
Loading Comments...